22nd Century Group Competitors

22nd Century Group (NYSEAMERICAN:XXII) and Innovative Industrial Properties (NYSE:IIPR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Institutional and Insider Ownership

74.9% of Innovative Industrial Properties shares are held by institutional investors. 2.9% of Innovative Industrial Properties shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares 22nd Century Group and Innovative Industrial Properties' gross revenue, earnings per share (EPS) and valuation.

Innovative Industrial Properties has higher revenue and earnings than 22nd Century Group.

Profitability

This table compares 22nd Century Group and Innovative Industrial Properties' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and Innovative Industrial Properties, as reported by MarketBeat.

Innovative Industrial Properties has a consensus target price of $192.4286, indicating a potential upside of 6.23%. Given Innovative Industrial Properties' higher possible upside, analysts plainly believe Innovative Industrial Properties is more favorable than 22nd Century Group.

Summary

Innovative Industrial Properties beats 22nd Century Group on 8 of the 9 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and GrowGeneration (NASDAQ:GRWG) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Institutional and Insider Ownership

51.3% of GrowGeneration shares are held by institutional investors. 13.6% of GrowGeneration shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares 22nd Century Group and GrowGeneration's gross revenue, earnings per share (EPS) and valuation.

GrowGeneration has higher revenue and earnings than 22nd Century Group.

Profitability

This table compares 22nd Century Group and GrowGeneration's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and GrowGeneration, as reported by MarketBeat.

GrowGeneration has a consensus target price of $49.5714, indicating a potential upside of 10.50%. Given GrowGeneration's higher possible upside, analysts plainly believe GrowGeneration is more favorable than 22nd Century Group.

Summary

GrowGeneration beats 22nd Century Group on 8 of the 9 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and KushCo (OTCMKTS:KSHB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Institutional and Insider Ownership

0.0% of KushCo shares are held by institutional investors. 17.3% of KushCo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares 22nd Century Group and KushCo's gross revenue, earnings per share (EPS) and valuation.

22nd Century Group has higher earnings, but lower revenue than KushCo.

Profitability

This table compares 22nd Century Group and KushCo's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and KushCo, as reported by MarketBeat.

KushCo has a consensus target price of $1.8750, indicating a potential upside of 58.90%. Given KushCo's higher possible upside, analysts plainly believe KushCo is more favorable than 22nd Century Group.

Summary

KushCo beats 22nd Century Group on 5 of the 9 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and NSAV (OTCMKTS:NSAV) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Earnings & Valuation

This table compares 22nd Century Group and NSAV's gross revenue, earnings per share (EPS) and valuation.

Profitability

This table compares 22nd Century Group and NSAV's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and NSAV, as reported by MarketBeat.

Summary

22nd Century Group beats NSAV on 1 of the 1 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and Terra Tech (OTCMKTS:TRTC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Institutional and Insider Ownership

0.1% of Terra Tech shares are held by institutional investors. 6.7% of Terra Tech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares 22nd Century Group and Terra Tech's gross revenue, earnings per share (EPS) and valuation.

22nd Century Group has higher earnings, but lower revenue than Terra Tech.

Profitability

This table compares 22nd Century Group and Terra Tech's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and Terra Tech, as reported by MarketBeat.

Summary

22nd Century Group beats Terra Tech on 4 of the 7 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and General Cannabis (OTCMKTS:CANN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Profitability

This table compares 22nd Century Group and General Cannabis' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 22nd Century Group and General Cannabis, as reported by MarketBeat.

Earnings & Valuation

This table compares 22nd Century Group and General Cannabis' gross revenue, earnings per share (EPS) and valuation.

22nd Century Group has higher earnings, but lower revenue than General Cannabis.

Summary

22nd Century Group beats General Cannabis on 3 of the 4 factors compared between the two stocks.